Genomics and Bioinformatics Group Genomics and Bioinformatics Group Genomics and Bioinformatics Group
Genomics and Bioinformatics Group

2000 Publication

Genomics and Bioinformatics Group
  Home
  Tools
  Molec Maps
  Members
  Contact
Publications
      2020
      2019
      2018
      2017
      2016
      2015
      2014
      2013
      2012
      2011
      2010
      2009
      2008
      2007
      2006
      2005
      2004
      2003
      2002
      2001
      2000
      1999
      Before 1999
      Selected
 

Mining and Visualizing Large Anticancer Drug Discovery Databases

Leming M. Shi, Jae K. Lee, Yi Fan, Timothy G. Myers, Mark Waltham, Darren T. Andrews, Uwe Scherf, Kenneth D. Paull, and John N. Weinstein.

J Chem Inf Comput Sci 2000

In order to find more effective anticancer drugs, the U.S. National Cancer Institute (NCI) screens a large number of compounds in vitro against 60 human cancer cell lines from different organs of origin.  About 70,000 compounds have been tested in the program since 1990, and each tested compound can be characterized by a vector (i.e. "fingerprint") of 60 anticancer activity, or -[log(GI50 ], values.  GI50 is the concentration required to inhibit cell growth by 50% compared with untreated controls.  Although cell growth inhibitory activity for a single cell line is not very informative, activity patterns across the 60 cell lines can provide incisive information on the mechanisms of action of screened compounds and also on molecular targets and modulators of activity within the cancer cells.  Various statistical and artificial intelligence methods, including principal component analysis, hierarchical cluster analysis, stepwise linear regression, multidimensional scaling, neural network modeling, and genetic function approximation, among others, can be used to analyze this large activity database.  Mining the database can provide useful information: (a) for the development of anticancer drugs; (b) for a better understanding of the molecular pharmacology of cancer; and (c) for improvement of the drug discovery process.


Genomics and Pharmacology Facility
                Home Page Link to Center for Cancer Research Home Page Link to National Cancer Institute Home Page Link to National Institutes of Health Link to Department of Health & Human Services Home Page